Trestle Bio Partners with Humacyte to Revolutionize Kidney Transplant Technology
Trestle Biotherapeutics and Humacyte (Nasdaq: HUMA) have announced a research collaboration to explore technology synergies for bioengineering...
Trestle Biotherapeutics and Humacyte (Nasdaq: HUMA) have announced a research collaboration to explore technology synergies for bioengineering...